Table 1 –
Primary Healthcare Utilization and HCC Surveillance Subgroup Cohort Characteristics
| Factor | Healthcare Utilization Cohort (Cohort 1) N=68,673 |
HCC Surveillance Cohort (Cohort 2) N=28,678 |
|---|---|---|
| Age, median (IQR) | 63 (57.6, 68.2) | 61.6 (56.7, 66) |
| Sex | ||
| Female | 2426 (3.5%) | 978 (3.4%) |
| Male | 66247 (96.5%) | 27700 (96.6%) |
| Race/Ethnicity | ||
| White | 42604 (62.0%) | 17378 (60.6%) |
| Black | 14442 (21.0%) | 6487 (22.6%) |
| Hispanic | 5311 (7.7%) | 2371 (8.3%) |
| Asian | 1010 (1.5%) | 396 (1.4%) |
| Other | 5306 (7.7%) | 2046 (7.1%) |
| BMI, median (IQR) | 29.0 (25.4, 33.3) | 29.1 (25.6, 33.3) |
| Etiology | ||
| Hepatitis C virus (HCV) | 16424 (24.0%) | 8481 (29.6%) |
| Hepatitis B virus | 808 (1.2%) | 391 (1.4%) |
| Alcohol-related liver disease (ALD) | 19106 (27.9%) | 7130 (24.9%) |
| HCV+ALD | 11946 (17.4%) | 5355 (18.7%) |
| Non-alcoholic fatty liver disease | 17730 (25.9%) | 6278 (21.9%) |
| Other | 2552 (3.7%) | 1021 (3.6%) |
| CTP Class | ||
| A | 59535 (86.7%) | 25926 (90.4%) |
| B | 8444 (12.3%) | 2752 (9.6%) |
| C | 694 (1.0%) | 0 (0.0%) |
| MELD-Na, median (IQR) | 8 (6, 12) | 7 (6, 11) |
| Cirrhosis Decompensation | 19926 (29.0%) | 9670 (33.7%) |
| Diabetes Mellitus | 37797 (55.0%) | 16132 (56.3%) |
| Atrial Fibrillation | 10165 (14.8%) | 3964 (13.8%) |
| Coronary Artery Disease | 19690 (28.7%) | 8453 (29.5%) |
| Heart Failure | 11914 (17.3%) | 4771 (16.6%) |
| Academic Center | 42257 (61.5%) | 17838 (62.2%) |
| U.S. Region | ||
| Northeast | 8958 (13.0%) | 3835 (13.4%) |
| Southeast | 17220 (25.1%) | 7134 (24.9%) |
| Midsouth | 15892 (23.1%) | 6558 (22.9%) |
| Central | 10504 (15.3%) | 4392 (15.3%) |
| West | 15547 (22.6%) | 6503 (22.7%) |
| Other | 552 (0.8%) | 256 (0.9%) |
| Center Advanced Liver Disease Dashboard Usage | ||
| Not Using | 2009 (7.0%) | |
| Intermittent Use | 5897 (20.6%) | |
| Routine Use | 20772 (72.4%) |